Morris Pfeffer

804 total citations
20 papers, 634 citations indexed

About

Morris Pfeffer is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Morris Pfeffer has authored 20 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Morris Pfeffer's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Morris Pfeffer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Morris Pfeffer collaborates with scholars based in United States, Japan and Belgium. Morris Pfeffer's co-authors include Charlotte Ressler, André J. Jackson, Robert D. Smyth, G. H. Hottendorf, Donald R. Van Harken, Markku Anttila, M Arstila, Hannu Sundquist, Alan A. Rubin and Richard E. Gammans and has published in prestigious journals such as Nature, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Morris Pfeffer

20 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morris Pfeffer United States 14 206 97 83 73 69 20 634
Edward J. Mroszczak United States 13 360 1.7× 118 1.2× 101 1.2× 59 0.8× 136 2.0× 26 794
M. Mitchard United Kingdom 17 287 1.4× 142 1.5× 93 1.1× 117 1.6× 150 2.2× 57 884
Robert C. Sonders United States 12 156 0.8× 75 0.8× 56 0.7× 33 0.5× 44 0.6× 18 441
Denis Lamiable France 16 168 0.8× 125 1.3× 76 0.9× 74 1.0× 81 1.2× 73 770
B Calesnick United States 11 150 0.7× 103 1.1× 45 0.5× 60 0.8× 50 0.7× 39 528
Heather A. Friedel 10 149 0.7× 197 2.0× 37 0.4× 50 0.7× 72 1.0× 11 797
Joseph N. Miceli United States 13 178 0.9× 78 0.8× 36 0.4× 66 0.9× 107 1.6× 33 471
H Vergin Switzerland 11 177 0.9× 81 0.8× 53 0.6× 29 0.4× 67 1.0× 56 544
John S. Wold United States 14 236 1.1× 97 1.0× 48 0.6× 53 0.7× 57 0.8× 24 448
M. A. P. Meisinger United States 11 383 1.9× 140 1.4× 52 0.6× 42 0.6× 70 1.0× 16 708

Countries citing papers authored by Morris Pfeffer

Since Specialization
Citations

This map shows the geographic impact of Morris Pfeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Pfeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Pfeffer more than expected).

Fields of papers citing papers by Morris Pfeffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morris Pfeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Pfeffer. The network helps show where Morris Pfeffer may publish in the future.

Co-authorship network of co-authors of Morris Pfeffer

This figure shows the co-authorship network connecting the top 25 collaborators of Morris Pfeffer. A scholar is included among the top collaborators of Morris Pfeffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morris Pfeffer. Morris Pfeffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shyu, Wen Chyi, Robert F. Mayol, Morris Pfeffer, et al.. (1993). Biopharmaceutical evaluation of transnasal, sublingual, and buccal disk dosage forms of butorphanol. Biopharmaceutics & Drug Disposition. 14(5). 371–379. 29 indexed citations
2.
Gammans, Richard E., et al.. (1987). Lack of Interaction Between Cimetidine and Buspirone. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 7(3). 72–79. 10 indexed citations
3.
Wajsman, Zev, et al.. (1984). Studies of Mitomycin C Absorption After Intravesical Treatment of Superficial Bladder Tumors. The Journal of Urology. 132(1). 30–32. 17 indexed citations
4.
Alford, Robert H., et al.. (1981). Ceforanide kinetics in renal insufficiency. Clinical Pharmacology & Therapeutics. 30(4). 468–474. 8 indexed citations
5.
Pfeffer, Morris, et al.. (1980). Comparative Pharmacokinetics of Ceforanide (BL-S786R) and Cefazolin in Laboratory Animals and Humans. Antimicrobial Agents and Chemotherapy. 17(2). 188–192. 46 indexed citations
6.
Pfeffer, Morris, Robert C. Gaver, & Donald R. Van Harken. (1980). Human Pharmacokinetics of a New Broad-Spectrum Parenteral Cephalosporin Antibiotic, Ceforanide. Journal of Pharmaceutical Sciences. 69(4). 398–403. 13 indexed citations
7.
Smyth, Robert D., et al.. (1979). Clinical Pharmacokinetics and Safety of High Doses of Ceforanide (BL-S786R) and Cefazolin. Antimicrobial Agents and Chemotherapy. 16(5). 615–621. 31 indexed citations
8.
Pfeffer, Morris, et al.. (1977). Comparative Human Oral Clinical Pharmacology of Cefadroxil, Cephalexin, and Cephradine. Antimicrobial Agents and Chemotherapy. 11(2). 331–338. 104 indexed citations
9.
Anttila, Markku, et al.. (1976). Human Pharmacokinetics of Sotalol. Acta Pharmacologica et Toxicologica. 39(1). 118–128. 83 indexed citations
10.
Pfeffer, Morris. (1975). Drug Metabolism Reviews. Journal of Pharmaceutical Sciences. 64(10). 1735–1735. 98 indexed citations
11.
Pfeffer, Morris, et al.. (1973). Narcotic and narcotic antagonist analgesics: Their effect on rat brain monoamine oxidase in vitro. Toxicology and Applied Pharmacology. 24(2). 333–335. 1 indexed citations
12.
Pfeffer, Morris. (1973). COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution. Journal of Pharmacokinetics and Biopharmaceutics. 1(2). 137–163. 43 indexed citations
13.
Pfeffer, Morris, et al.. (1972). Intestinal Sorption of Anisotropine Methylbromide in the Rat. Journal of Pharmaceutical Sciences. 61(8). 1223–1227. 7 indexed citations
14.
Pfeffer, Morris, et al.. (1968). Human Urinary Excretion of the Quaternary Ammonium Compounds Anisotropine Methylbromide and Propantheline Bromide. Journal of Pharmaceutical Sciences. 57(8). 1375–1379. 15 indexed citations
15.
Pfeffer, Morris, et al.. (1968). Human Urinary Excretion of Orally Administered Anisotropine Methylbromide. Journal of Pharmaceutical Sciences. 57(1). 36–38. 7 indexed citations
16.
Pfeffer, Morris & Charlotte Ressler. (1967). β-Cyanoalanine, an inhibitor of rat liver cystathionase. Biochemical Pharmacology. 16(12). 2299–2308. 60 indexed citations
17.
Ressler, Charlotte, et al.. (1967). Metabolism of β-cyanoalanine. Biochemical Pharmacology. 16(12). 2309–2319. 15 indexed citations
18.
Rubin, Alan A., et al.. (1967). Psychopharmacological Profile of Molindone. Nature. 216(5115). 578–579. 28 indexed citations
19.
Ressler, Charlotte, et al.. (1964). A Pyridoxal-β-Cyanoalanine Relation in the Rat. Nature. 203(4951). 1286–1287. 13 indexed citations
20.
Pfeffer, Morris & Stanley K. Shapiro. (1962). Biosynthesis of methionine from S-adenosylmethionine in Escherichia, coli. Biochemical and Biophysical Research Communications. 9(5). 405–409. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward J. Mroszczak Breakdown of academic impact, for papers by M. Mitchard Breakdown of academic impact, for papers by Robert C. Sonders Breakdown of academic impact, for papers by Denis Lamiable Breakdown of academic impact, for papers by B Calesnick Breakdown of academic impact, for papers by Heather A. Friedel Breakdown of academic impact, for papers by Joseph N. Miceli Breakdown of academic impact, for papers by H Vergin Breakdown of academic impact, for papers by John S. Wold Breakdown of academic impact, for papers by M. A. P. Meisinger
Rankless by CCL
2026